These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 24828489

  • 1. No chemopreventive effect of nonsteroidal anti-inflammatory drugs on nonmelanoma skin cancer: evidence from meta-analysis.
    Zhang B, Liang X, Ye L, Wang Y.
    PLoS One; 2014; 9(5):e96887. PubMed ID: 24828489
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Nonsteroidal anti-inflammatory drugs and the risk of nonmelanoma skin cancer.
    Reinau D, Surber C, Jick SS, Meier CR.
    Int J Cancer; 2015 Jul 01; 137(1):144-53. PubMed ID: 25418602
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Aspirin and nonsteroidal anti-inflammatory drug use and keratinocyte cancers: a large population-based cohort study of skin cancer in Australia.
    Pandeya N, Olsen CM, Thompson BS, Dusingize JC, Neale RE, Green AC, Whiteman DC, QSkin Study.
    Br J Dermatol; 2019 Oct 01; 181(4):749-760. PubMed ID: 30920641
    [Abstract] [Full Text] [Related]

  • 7. Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer: a critical review of the literature and meta-analysis.
    Marcil I, Stern RS.
    Arch Dermatol; 2000 Dec 01; 136(12):1524-30. PubMed ID: 11115165
    [Abstract] [Full Text] [Related]

  • 8. The association between nonsteroidal anti-inflammatory drugs and skin cancer: Different responses in American and European populations.
    Ma Y, Yu P, Lin S, Li Q, Fang Z, Huang Z.
    Pharmacol Res; 2020 Feb 01; 152():104499. PubMed ID: 31689521
    [Abstract] [Full Text] [Related]

  • 9. Analgesic and nonsteroidal anti-inflammatory use in relation to nonmelanoma skin cancer: a population-based case-control study.
    Torti DC, Christensen BC, Storm CA, Fortuny J, Perry AE, Zens MS, Stukel T, Spencer SK, Nelson HH, Karagas MR.
    J Am Acad Dermatol; 2011 Aug 01; 65(2):304-312. PubMed ID: 21529996
    [Abstract] [Full Text] [Related]

  • 10. Intralesional 5-Fluorouracil for Treatment of Non-Melanoma Skin Cancer: A Systematic Review.
    Maghfour J, Kuraitis D, Murina A.
    J Drugs Dermatol; 2021 Feb 01; 20(2):192-198. PubMed ID: 33538569
    [Abstract] [Full Text] [Related]

  • 11. Risk of basal cell and squamous cell skin cancers after ionizing radiation therapy. For The Skin Cancer Prevention Study Group.
    Karagas MR, McDonald JA, Greenberg ER, Stukel TA, Weiss JE, Baron JA, Stevens MM.
    J Natl Cancer Inst; 1996 Dec 18; 88(24):1848-53. PubMed ID: 8961975
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Personal history of psoriasis and risk of nonmelanoma skin cancer (NMSC) among women in the United States: A population-based cohort study.
    Dai H, Li WQ, Qureshi AA, Han J.
    J Am Acad Dermatol; 2016 Oct 18; 75(4):731-735. PubMed ID: 27436157
    [Abstract] [Full Text] [Related]

  • 15. Nonmelanoma skin cancer and risk of all-cause and cancer-related mortality: a systematic review.
    Barton V, Armeson K, Hampras S, Ferris LK, Visvanathan K, Rollison D, Alberg AJ.
    Arch Dermatol Res; 2017 May 18; 309(4):243-251. PubMed ID: 28285366
    [Abstract] [Full Text] [Related]

  • 16. Nonsteroidal anti-inflammatory drugs and risk of ovarian cancer: systematic review and meta-analysis of observational studies.
    Baandrup L, Faber MT, Christensen J, Jensen A, Andersen KK, Friis S, Kjaer SK.
    Acta Obstet Gynecol Scand; 2013 Mar 18; 92(3):245-55. PubMed ID: 23240575
    [Abstract] [Full Text] [Related]

  • 17. Topical imiquimod therapy for basal and squamous cell carcinomas: a clinical experience.
    Tillman DK, Carroll MT.
    Cutis; 2007 Mar 18; 79(3):241-8. PubMed ID: 17674590
    [Abstract] [Full Text] [Related]

  • 18. Changing demographics and pathology of nonmelanoma skin cancer in the last 30 years.
    Collins GL, Nickoonahand N, Morgan MB.
    Semin Cutan Med Surg; 2004 Mar 18; 23(1):80-3. PubMed ID: 15095919
    [Abstract] [Full Text] [Related]

  • 19. Nonsteroidal anti-inflammatory drugs and the risk of skin cancer: a population-based case-control study.
    Johannesdottir SA, Chang ET, Mehnert F, Schmidt M, Olesen AB, Sørensen HT.
    Cancer; 2012 Oct 01; 118(19):4768-76. PubMed ID: 22644960
    [Abstract] [Full Text] [Related]

  • 20. Oral therapy for nonmelanoma skin cancer in patients with advanced disease and large tumor burden: a review of the literature with focus on a new generation of targeted therapies.
    Rudnick EW, Thareja S, Cherpelis B.
    Int J Dermatol; 2016 Mar 01; 55(3):249-58; quiz 256, 258. PubMed ID: 26566923
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.